Advertisement

Topics

Teva to file for approval of SD-809 following more positive top-line Ph III results in tardive dyskinesia

09:19 EDT 23 Sep 2016 | thePharmaLetter

Teva Pharmaceutical Industries has announced that SD-809 (deutetrabenazine) showed statistically-significant…

Original Article: Teva to file for approval of SD-809 following more positive top-line Ph III results in tardive dyskinesia

NEXT ARTICLE

More From BioPortfolio on "Teva to file for approval of SD-809 following more positive top-line Ph III results in tardive dyskinesia"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...